  |
 | Up a level |
Long, G.V. and Flaherty, K.T. and Stroyakovskiy, D. and Gogas, H. and Levchenko, E. and de Braud, F. and Larkin, J. and Garbe, C. and Jouary, T. and Hauschild, A. and Chiarion-Sileni, V. and Lebbe, C. and Mandala, M. and Millward, M. and Arance, A. and Bondarenko, I. and Haanen, J.B.A.G. and Hansson, J. and Utikal, J. and Ferraresi, V. and Mohr, P. and Probachai, V. and Schadendorf, D. and Nathan, P. and Robert, C. and Ribas, A. and Davies, M.A. and Lane, S.R. and Legos, J.J. and Mookerjee, B. and Grob, J.-J. (2017) Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/ K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. Annals of Oncology, Vol.28 (Iss. 7). pp. 1631-1639. ISSN 0923-7534 (Print), 1569-8041 (Electronic)
Long, G.V. and Stroyakovskiy, D. and Gogas, H. and Levchenko, E. and de Braud, F. and Larkin, J. and Garbe, C. and Jouary, T. and Hauschild, A. and Grob, J.J. and Chiarion Sileni, V. and Lebbe, C. and Mandalà, M. and Millward, M. and Arance, A. and Bondarenko, I. and Haanen, J.B.A.G. and Hansson, J. and Utikal, J. and Ferraresi, V. and Kovalenko, N. and Mohr, P. and Probachai, V. and Schadendorf, D. and Nathan, P. and Robert, C. and Ribas, A. and DeMarini, D.J. and Irani, J.G. and Casey, M. and Ouellet, D. and Martin, A.-M. and Le, N. and Patel, K. and Flaherty, K. (2014) Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma. The New England Journal of Medicine = N Engl J Med, 371. pp. 1877-1888. ISSN 0028-4793 (print); 1533-4406 (online)
